Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-01-06 @ 8:06 AM
Study NCT ID:
NCT03123094
Status:
COMPLETED
Last Update Posted:
2024-03-06
First Post:
2017-04-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Single Rising Dose Trial of Spesolimab (BI 655130) for Healthy Japanese Male Subjects
Sponsor:
Boehringer Ingelheim
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1368-0009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None